[ad_1] Insulin still unaffordable to some after price caps – CBS News Watch CBS News The maximum monthly price for insulin was recently capped at $35 for millions. But many don’t qualify and struggle to afford the life-saving medication. Roxana Saberi has more. Be the first to know Get browser notifications for breaking news, live…
[ad_1] Fighting rising prescription drug costs Fighting rising prescription drug costs 07:59 Pharmaceutical companies are hiking prices for more than 700 medications, including popular weight-loss drugs Ozempic and Mounjaro, industry research shows. The average price increase at year start was about about 4.5%, the analysis from 46 Brooklyn found. That represents a slightly slower pace…
[ad_1] The U.S. Food and Drug Administration approves Eli Lilly’s Zepbound drug for weight loss – CBS News Watch CBS News The FDA has approved Eli Lilly’s Zepbound drug for weight loss. It’s set to hit the market by the end of the year. Nancy Chen has more. Be the first to know Get browser…
[ad_1] The Food and Drug Administration approved a request by Eli Lilly on Wednesday to begin marketing its tirzepatide medication, which is branded as Mounjaro for diabetes, under a new brand for weight loss as well. While Mounjaro had already been used by some patients “off-label” for weight loss, the new FDA approval will allow…
[ad_1] Jack Hanna’s family recently spoke about his Alzheimer’s diagnosis for the first time publicly. The zookeeper and media personality’s family spoke to The Columbus Dispatch about the disease, which affects cognitive function and memory, saying it has progressed to the point where Hanna doesn’t know most of his family. Hanna, who served as director…
[ad_1] A new experimental drug shows promise in fight against Alzheimer’s – CBS News Watch CBS News Drugmaker Eli Lilly says its new antibody infusion could slow cognitive decline in Alzheimer’s patients. Be the first to know Get browser notifications for breaking news, live events, and exclusive reporting. Not Now Turn On [ad_2] Source link
[ad_1] Eli Lilly said Wednesday its experimental Alzheimer’s drug appeared to slow worsening of the mind-robbing disease in a large study, sending its stock up by 5% on investor optimism about the results. In the 18-month trial, people in the early stages of Alzheimer’s who received infusions of donanemab showed 35% less decline in thinking…
[ad_1] Eli Lilly seeks FDA approval for weight loss drug tirzepatide – CBS News Watch CBS News Pharmaceutical giant Eli Lilly is requesting fast-track approval from the Food and Drug Administration for its Type 2 diabetes medication tirzepatide to be sold as a weight loss drug. The company said that new studies have shown promising…
